Find the product you need

News

Viromag Rl 200 Magnetic Transduction Reagent

Catalog number: RL40200
Brand: OZ Biosciences
Packing: 200 ul
Price: € 227.00
Expected delivery time: 5 days
Quantity:
Spin UpSpin Down

Product specifications for - Viromag Rl 200 Magnetic Transduction Reagent

Overview: 
Product group: Molecular Biology
Category: Transfection / transduction
Subcategory: Transduction
Properties: 
Datasheet: Datasheet
  Research Use Only
UNSPSC: 41116133
Scientific information: 
Scientific info: ViroMag R/L Transduction Reagent is a magnetic nanoparticles formulation optimized for Retroviruses and Lentiviruses. Based on the Magnetofection™ technology, this reagent allows concentrating the complete applied dose of Retro/Lentiviral particles onto cells within minutes, inducing a significant improvement of virus infectivity with extremely low vector doses. Due to its specific properties, ViroMag R/L is ideal to infect non permissive cells. This reagent demonstrates an exceptionally high efficiency to promote, control and assist viral transductions in a so that no molecular biology processes or biochemical modifications are required.
  • Increase transduction efficiency
  • Accelerate the transduction process
  • Efficient for hard-to-infect and non-permissive cells
  • Concentrate the viral dose onto the cells
  • Suitable for all type of Retro/Lentivirus
  • Synchronise cells adsorption/infection without modifications of the viruses
Safety information: 
MSDS: MSDS
Additional information: 
Synonyms: RL40200; OZ Biosciences; Viral Transduction; Lentivirus; Retrovirus; Magnetofection
Cuppoletti J, Tewari KP, Chakrabarti J, Malinowska DH. Identification of the fatty acid activation site on human ClC-2. Am J Physiol, Cell Physiol. 2017;312(6):C707-C723. Read more
De beer FM, Aslami H, Hoeksma J, et al. Plasma-derived human C1-esterase inhibitor does not prevent mechanical ventilation-induced pulmonary complement activation in a rat model of Streptococcus pneumoniae pneumonia. Cell Biochem Biophys. 2014;70(2):795-803. Read more
Debattisti V, Pendin D, Ziviani E, Daga A, Scorrano L. Reduction of endoplasmic reticulum stress attenuates the defects caused by Drosophila mitofusin depletion. J Cell Biol. 2014;204(3):303-12. Read more
Deguchi M, Kagita M, Yoshioka N, et al. Evaluation of the highly sensitive chemiluminescent enzyme immunoassay "Lumipulse HBsAg-HQ" for hepatitis B virus screening. J Clin Lab Anal. 2018;32(4):e22334. Read more
Deiss K, Lockwood N, Howell M, et al. A genome-wide RNAi screen identifies the SMC5/6 complex as a non-redundant regulator of a Topo2a-dependent G2 arrest. Nucleic Acids Res. 2019;47(6):2906-2921. Read more
Devaud C, Tilkin-mariamé AF, Vignolle-vidoni A, et al. FAK alternative splice mRNA variants expression pattern in colorectal cancer. Int J Cancer. 2019;145(2):494-502. Read more
Di scala C, Tessier M, Sapet C, et al. A new polymer-based approach for in vivo transfection in postnatal brain. J Neurosci Methods. 2019;311:295-306. Read more
Donnelly JM, Engevik A, Feng R, et al. Mesenchymal stem cells induce epithelial proliferation within the inflamed stomach. Am J Physiol Gastrointest Liver Physiol. 2014;306(12):G1075-88. Read more
Dubash TD, Hoffmann CM, Oppel F, et al. Phenotypic differentiation does not affect tumorigenicity of primary human colon cancer initiating cells. Cancer Lett. 2016;371(2):326-33. Read more
Dumon C, Diabira D, Chudotvorova I, et al. The adipocyte hormone leptin sets the emergence of hippocampal inhibition in mice. Elife. 2018;7 Read more
See All